Not known Facts About zanubrutinib
No adverse outcomes on embryo-fetal advancement had been observed in pregnant rabbits dealt with orally with doses as many as 100 mg/kg/day elafibranor, which generated systemic exposures (merged AUC for elafibranor and GFT1007) through the period of organogenesis that were a lot less than the human exposure. Administration of three hundred mg/kg/w